Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|April 8, 2017
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M2 Muscarinic Acetylcholine ReceptorAndrea Pegoli, Xueke She, David Wifling, et al.
Bioorganic & Medicinal Chemistry|April 16, 2011
Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological toolsMax Keller, Daniela Erdmann, Nathalie Pop, et al.
Scientific Reports|September 2, 2022
Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumorsLisa Schindler, Katrin Wohlfahrt, Lara Gluhacevic von Krüchten, et al.
Chemmedchem|June 22, 2011
Application of the guanidine-acylguanidine bioisosteric approach to argininamide-type NPY Y₂ receptor antagonistsNikola Pluym, Albert Brennauer, Max Keller, et al.
ACS Omega|July 20, 2018
Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M2R Affinity and SelectivityXueke She, Andrea Pegoli, Judith Mayr, et al.
Journal of Rehabilitation Medicine|December 16, 2022
Six Minutes Walking in Polio Survivors: Effects on Fatigue and Walking AdaptabilityJana Tuijtelaars, Max Keller, Frans Nollet, et al.
Nanoscale Horizons|February 14, 2025
The quantity of ligand-receptor interactions between nanoparticles and target cellsKathrin Schorr, Sebastian Beck, Oliver Zimmer, et al.
Journal of Medicinal Chemistry|May 26, 2016
High Affinity Agonists of the Neuropeptide Y (NPY) Y4 Receptor Derived from the C-Terminal Pentapeptide of Human Pancreatic Polypeptide (hPP): Synthesis, Stereochemical Discrimination, and RadiolabelingKilian K Kuhn, Thomas Ertl, Stefanie Dukorn, et al.
Plos One|December 14, 2012
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenograftsMartin Memminger, Max Keller, Miroslaw Lopuch, et al.
Bioorganic & Medicinal Chemistry|February 5, 2015
M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) bindingMax Keller, Christian Tränkle, Xueke She, et al.
Pageof 7